StockData
AbbVie Inc. logo

AbbVie Inc.

ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 10/3094% above fair value
$288.84−6.05 (-2.05%)

Close on Nov 2, 2026Market cap $510.41BP/E 81.6Yield 2.30%

AbbVie Other Post-Employment Benefit (OPEB) Plans by Year

Other Post-Employment Benefit (OPEB) Plans — Benefit Obligation [year-end] ($M) ($M)

AbbVie Other Post-Employment Benefit (OPEB) Plans: $822M in FY2025, up 4.6% from a year earlier.

Latest, FY2025
822
Period ended Dec 31, 2025
Change on a year earlier
+4.6%
786 in FY2024
History
11 years
Since FY2015
Sources
9
Documents cited below

Where the FY2025 figure comes from

Source: Form 10-K (filed 2026-02-20) ↗

Reported in Form 10-K Note 12 Post-Employment Benefits.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedOther Post-Employment Benefit (OPEB) Plans — Benefit Obligation [year-end] ($M) ($M)Year on yearSource
FY2025Dec 31, 2025822+4.6%Form 10-K (filed 2026-02-20) ↗
FY2024Dec 31, 2024786-1.3%Form 10-K (filed 2026-02-20) ↗
FY2023Dec 31, 2023796+19.3%Form 10-K (filed 2026-02-20) ↗
FY2022Dec 31, 2022667-21.5%Form 10-K (filed 2025-02-14) ↗
FY2021Dec 31, 2021850+6.9%Form 10-K (filed 2024-02-20) ↗
FY2020Dec 31, 2020795-24.3%Form 10-K (filed 2023-02-17) ↗
FY2019Dec 31, 20191,050+87.2%Form 10-K (filed 2022-02-18) ↗
FY2018Dec 31, 2018561-31.0%Form 10-K (filed 2021-02-19) ↗
FY2017Dec 31, 2017813+29.7%Form 10-K (filed 2020-02-21) ↗
FY2016Dec 31, 2016627+12.6%Form 10-K (filed 2019-02-27) ↗
FY2015Dec 31, 2015557–Form 10-K (filed 2018-02-16) ↗

Breakdown

What makes up other Post-Employment Benefit (OPEB) Plans

Cite this data

StockData. (2026). AbbVie Other Post-Employment Benefit (OPEB) Plans ($M), annual FY2015–FY2025 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/db-opeb-pbo

See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.